• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
15. Risk Of Pregnancy In Women With Congenital Heart
 

15. Risk Of Pregnancy In Women With Congenital Heart

on

  • 2,255 views

 

Statistics

Views

Total Views
2,255
Views on SlideShare
2,255
Embed Views
0

Actions

Likes
0
Downloads
52
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    15. Risk Of Pregnancy In Women With Congenital Heart 15. Risk Of Pregnancy In Women With Congenital Heart Presentation Transcript

    • Risk of pregnancy in women with congenital heart disease Ng Soo Khai Med IV
    •  Number of women with congenital heart disease reaching childbearing age is growing owing to advances in medical and surgical treatment  Despite these advances, congenital heart disease remains an important cause of maternal mortality and morbidity during pregnancy  2nd leading cause of maternal mortality (second to suicide)
    • CHD Acyanotic  ASD  VSD  PDA Cyanotic  Tetralogy of Fallot  Tricuspid atresia  Transposition of great vessel  Persistent truncus arteriosus  Others
    • Adaptations in pregnancy  Imposes strain on heart and circulation leading to cardiorespiratory adaptations  Rise in intravascular volume resulting in raise cardiac output by 50% during the 1st and 2nd trimester  Reduction in systemic vascular resistance with fall in blood pressure  Results in deterioration in women with CHD
    •  Hypercoagulable state – increase in Vit K dependent clotting factors and reduction in protein S  Increased in thromboembolic risk from uterus compression on IVC resulting in lower extremity venous stasis
    • Risks to mother Cardiac complications  Symptomatic arrhythmia  Congestive heart failure  Cardiovascular event  Endocarditis Obstetrical complications  Thromboembolic complications  Pre-eclampsia  Postpartum hemorrhage
    •  Arrhythmia - mostly supraventricular origin. Higher risk in TGA, AVSD, Fontan repair  Heart failure - mostly in cyanotic heart disease, Eisenmenger syndrome, and PAVSD  Cardiovascular events such as MI, stroke are seen mostly in those with Eisenmenger  Endocarditis – during labor and delivery. Simple ASD appear to be a greater risk.
    •  Thromboembolic complications – substantially higher than normal population A study of 688 pregnant women with CHD, incidence of thromboembolic events: - 2% in CHD compare to - 0.05-0.10% in normal pregnancy  Preeclampsia - cluster in patients with aortic coarctation, PS, PAVSD, and TGA.
    • Risks to fetus  Spontaneous abortion  Premature birth  Intrauterine growth restriction (IUGR)  Fetal & perinatal mortality  Congenital heart disease
    •  Premature birth – rate of 16%, higher than generally population 10%  Fetal and perinatal mortality - ~4% in CHD compare to <1% in normal. As high as 27% in Eisenmenger  Recurrence of CHD - risk is higher - 5.7% if mother had CHD - 2.2% if the father had CHD
    •  Predictors for maternal and fetal complications : - Pulmonary hypertension - Maternal cyanosis - Preconception history of adverse cardiac events eg MI, arrhythmia, TIA - Left heart obstruction (mitral valve area <2cm, aortic valve <1.5cm)
    •  New data shows no increase risk in maternal mortality in women with CHD uncomplicated by Eisenmenger’s syndrome.  Only mothers with Eisenmenger’s syndrome have substantial mortality during pregnancy of 10-30%
    • Pulmonary Hypertension  most serious risk especially Eisenmenger syndrome Eisenmenger syndrome  reversal of shunt in the setting of initial left-to- right shunt due to development of pulmonary hypertension  drop in systemic resistance that accompanied pregnancy amplify the shunt reversal  body cannot compensate such short term changes  severe and potentially fatal hypoxemia during pregnancy or postpartum period
    •  poorly tolerate the hemodynamic changes associated with pregnancy and susceptible to complications like preeclampsia and postpartum hemorrhage  50% - preterm delivery and fetal growth retardation  Only 15-25% progress to full term  Pregnancy is contraindicated in women with Eisenmenger syndrome
    • Cyanosis  Arterial oxygen saturation before pregnancy – important predictor Data from 104 pregnancies in 74 women with CHD: - 90% with cyanotic CHD - 19% with acyanotic CHD had significant postpartum complications  Arterial O2 saturation below 80% increases the risks  No evidence that high sat O2 administration benefits the mother
    •  Mother with cyanotic CHD without pulmonary hypertension, maternal risk is low but fetal risk is high. 96 pregnancies of cyanotic CHD:  43% live birth, 37% of which were premature  Mean weight of full term infants – 2.5kg compare to normal 3.5kg
    •  One recent study reported a 12% likelihood of a livebirth when the arterial oxygen saturation at rest was < 85%;  Livebirth rate improved to 63% when the oxygen saturation was > 85%.
    •  Review of most retrospective reports from 1985-2006 that described the outcomes of 2491 pregnancies in women with CHD: - Cardiac complications in 11% - 5% - heart failure - 4.5% - arrhythmias - 15% miscarriage - 5% chose to terminate pregnancy - 16% premature birth - 4% small for gestational age - 2.3% perinatal mortality - 1.7% fetal mortality
    • THE END THANK YOU